Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs.
Cell Prolif
; 53(12): e12944, 2020 Dec.
Article
in English
| MEDLINE | ID: covidwho-892247
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pulmonary Fibrosis
/
T-Lymphocytes, Regulatory
/
Human Embryonic Stem Cells
/
COVID-19
Type of study:
Randomized controlled trials
Topics:
Long Covid
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Cell Prolif
Year:
2020
Document Type:
Article
Affiliation country:
Cpr.12944
Similar
MEDLINE
...
LILACS
LIS